SCHEMBL27237401

SCHEMBL27237401

CCOc1ccc(-c2cccc(C(=O)NN=Cc3cc(OC)cc(OC)c3)n2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 3/20 0.58
▸ MEN1 O00255 2/20 0.58
▸ ALDH1A1 P00352 6/20 0.51
▸ TP53 P04637 1/20 0.51
▸ HPGD P15428 4/20 0.50
▸ MGAM O43451 1/20 0.50
▸ CYP1A2 P05177 1/20 0.50
▸ GAA P10253 1/20 0.50
▸ CYP2C19 P33261 1/20 0.50
▸ RAB9A P51151 2/20 0.49
▸ MAPT P10636 4/20 0.49
▸ KDM4E B2RXH2 2/20 0.49
▸ HTT P42858 1/20 0.49
▸ SMN1; SMN2 Q16637 1/20 0.49
▸ POLB P06746 4/20 0.48
▸ DUSP3 P51452 1/20 0.48
▸ PTPN5 P54829 1/20 0.48
▸ PTPN11 Q06124 1/20 0.48
▸ CTDSP1 Q9GZU7 1/20 0.48
▸ NPC1 O15118 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25003158 1.00 KMT2A (0.58) KMT2AMEN1ALDH1A1TP53HPGD
SCHEMBL25003813 0.92 KMT2A (0.56) KMT2AMEN1ALDH1A1TP53HPGD
SCHEMBL27237483 0.92 KMT2A (0.56) KMT2AMEN1ALDH1A1TP53HPGD
SCHEMBL30862205 0.92 KMT2A (0.56) KMT2AMEN1ALDH1A1TP53HPGD
SCHEMBL25002946 0.92 KMT2A (0.56) KMT2AMEN1ALDH1A1TP53HPGD
SCHEMBL27237484 0.92 KMT2A (0.56) KMT2AMEN1ALDH1A1TP53HPGD
SCHEMBL25003809 0.92 KMT2A (0.69) KMT2AMEN1ALDH1A1TP53HPGD
SCHEMBL30951025 0.92 KMT2A (0.69) KMT2AMEN1ALDH1A1TP53HPGD
SCHEMBL27237446 0.92 KMT2A (0.69) KMT2AMEN1ALDH1A1TP53HPGD
SCHEMBL30925931 0.88 SCN2A (0.57) KMT2AMEN1ALDH1A1TP53HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4382101-A1 N-ACYLHYDRAZONE COMPOUNDS CAPABLE OF INHIBITING NAV1.7 AND/OR NAV1.8, PROCESSES FOR THE PREPARATION THEREOF, COMPOSITIONS, USES, METHODS FOR TREATMENT USING SAME, AND KITS Eurofarma Laboratórios S.A. (BR) 2024-06-12 — — EP claimed
EP-4382101-A1 N-ACYLHYDRAZONE COMPOUNDS CAPABLE OF INHIBITING NAV1.7 AND/OR NAV1.8, PROCESSES FOR THE PREPARATION THEREOF, COMPOSITIONS, USES, METHODS FOR TREATMENT USING SAME, AND KITS Eurofarma Laboratórios S.A. (BR) 2024-06-12 — — EP disclosed
Send feedback